Everyone wants access to the next breakthrough, but who decides who gets it, and at what cost? Without the proper infrastructure or commercialization experience, even the most well‑intentioned efforts can struggle to bridge the gap between vision and viability.  

Take Drs. Peyman Golshani and Daniel Aharoni, as an example. They spearheaded the development of Miniscope, a transformative tool for academic neuroscience research. While the technology was functional and gaining traction within the educational community, the team faced significant barriers in scaling its accessibility. 

That’s where we came in to help. 

• The challenge: Despite being offered as an open-source platform, the practical realities of sourcing components, assembling the product, and providing consistent user support posed critical roadblocks to Miniscope’s scaling.  

• The approach: NobleReach assisted in the refinement of the manufacturing process to streamline production, reduce costs, and pave the way for commercialization. 
  • Based on advice from NobleReach, Drs. Golshani and Aharoni also worked on enhancing Miniscope’s design to ensure it met user needs while remaining scalable for larger deployments.  
  • We also organized workshops and mentorship sessions to help Drs. Golshani and Aharoni develop a clearer understanding of potential customer segments and define a business model tailored to their technology’s unique position in the open-source market. 

• The impact: The Miniscope project has demonstrated significant potential to transform neuroscience research by providing an affordable and adaptable tool for a wide range of applications. With continued cross-sector support, Drs. Golshani and Aharoni are well-positioned to expand Miniscope’s reach and solidify its role as a cornerstone technology in neuroscience. 

What these challenges ultimately highlight is possibility, not limitation. They show exactly where open‑source innovation needs to evolve and where gaps exist in real-world execution. By understanding these gaps, we can build pathways that make future breakthroughs not only accessible in theory but truly usable in practice.